Cargando…

Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers

Interstitial lung diseases (ILDs) are a large group of pulmonary disorders characterized histologically by the cardinal involvement of the pulmonary interstitium. The prototype of ILDs is idiopathic pulmonary fibrosis (IPF), an incurable disease characterized by progressive distortion and loss of no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drakopanagiotakis, Fotios, Markart, Philipp, Steiropoulos, Paschalis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299235/ https://www.ncbi.nlm.nih.gov/pubmed/37373339 http://dx.doi.org/10.3390/ijms241210196

Ejemplares similares

The Role of the Microbiome in Connective-Tissue-Associated Interstitial Lung Disease and Pulmonary Vasculitis
por: Drakopanagiotakis, Fotios, et al.
Publicado: (2022)

Lung Cancer and Interstitial Lung Diseases: A Systematic Review
por: Archontogeorgis, Kostas, et al.
Publicado: (2012)

Acute exacerbations of progressive-fibrosing interstitial lung diseases
por: Kolb, Martin, et al.
Publicado: (2018)

Acute Exacerbation in Interstitial Lung Disease
por: Leuschner, Gabriela, et al.
Publicado: (2017)

Acute exacerbation in interstitial lung disease
por: Alhamad, Esam H., et al.
Publicado: (2021)

COVID-19 and acute exacerbation of interstitial lung disease
por: Kondoh, Yasuhiro, et al.
Publicado: (2021)

Cyclophosphamide for the treatment of Acute Exacerbation of Interstitial Lung Disease: A Review of the Literature
por: Innabi, Ayoub, et al.
Publicado: (2021)

The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases
por: Lee, Jae Ha, et al.
Publicado: (2021)

Therapeutic effect of nintedanib on acute exacerbation of interstitial lung diseases
por: Ito, Yoko, et al.
Publicado: (2019)

Acute exacerbations of interstitial lung disease: what is the best treatment?
por: Meyer, Keith C.
Publicado: (2021)

Acute exacerbation of interstitial lung disease in the intensive care unit
por: Charokopos, Antonios, et al.
Publicado: (2022)

Prevalence of viral infection in acute exacerbation of interstitial lung diseases in Japan
por: On, Rintaro, et al.
Publicado: (2020)

Serum biomarkers in interstitial lung diseases
por: Tzouvelekis, Argyris, et al.
Publicado: (2005)

Secondary analysis of preoperative predictors for acute postoperative exacerbation in interstitial lung disease
por: Seto, Fumiko, et al.
Publicado: (2023)

Acute Exacerbation of Interstitial Lung Disease as a Sequela of COVID-19 Pneumonia
por: Fonseca, Mario, et al.
Publicado: (2021)

Combined ultrasound–CT approach to monitor acute exacerbation of interstitial lung disease
por: Mongodi, Silvia, et al.
Publicado: (2020)

Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases
por: Salonen, Johanna, et al.
Publicado: (2020)

Biomarkers for interstitial lung disease and acute-onset diffuse interstitial lung disease in rheumatoid arthritis
por: Furukawa, Hiroshi, et al.
Publicado: (2021)

Rituximab for the treatment of acute exacerbation of interstitial lung disease associated with connective tissue disease
por: León Román, Francisco, et al.
Publicado: (2023)

Serum autotaxin levels in chronic disease and acute exacerbation of fibrosing interstitial lung disease
por: Isshiki, Takuma, et al.
Publicado: (2022)

Calcium Channel Blockers and Esophageal Sclerosis: Should We Expect Exacerbation of Interstitial Lung Disease?
por: Seretis, Charalampos, et al.
Publicado: (2012)

Pulmonary Sequelae of COVID-19: Focus on Interstitial Lung Disease
por: Johnston, Janet, et al.
Publicado: (2023)

Exploring the Ability of Electronic Nose Technology to Recognize Interstitial Lung Diseases (ILD) by Non-Invasive Breath Screening of Exhaled Volatile Compounds (VOC): A Pilot Study from the European IPF Registry (eurIPFreg) and Biobank
por: Krauss, Ekaterina, et al.
Publicado: (2019)

Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy
por: Sekine, Akimasa, et al.
Publicado: (2022)

Effect of compliance to continuous positive airway pressure on exacerbations, lung function and symptoms in patients with chronic obstructive pulmonary disease and obstructive sleep apnea (overlap syndrome)
por: Voulgaris, Athanasios, et al.
Publicado: (2023)

Incidence of acute exacerbation in patients with interstitial lung disease after COVID-19 vaccination
por: Sakayori, Masashi, et al.
Publicado: (2023)

Re-hospitalisation predicts poor prognosis after acute exacerbation of interstitial lung disease
por: Salonen, Johanna, et al.
Publicado: (2023)

Nintedanib administration after the onset of acute exacerbation of interstitial lung disease in the real world
por: Kato, Motoyasu, et al.
Publicado: (2023)

Predictors of postoperative acute exacerbation of interstitial lung disease: a case–control study
por: Hosoki, Keisuke, et al.
Publicado: (2020)

Clinical significance of respiratory virus detection in patients with acute exacerbation of interstitial lung diseases
por: Saraya, Takeshi, et al.
Publicado: (2018)

Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department
por: Jang, Hye Jin, et al.
Publicado: (2021)

Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
por: Faverio, Paola, et al.
Publicado: (2021)

Impact of Interstitial Lung Disease Classification on the Development of Acute Exacerbation of Interstitial Lung Disease and Prognosis in Patients with Stage III Non-Small-Cell Lung Cancer and Interstitial Lung Disease Treated With Chemoradiotherapy
por: Kobayashi, Haruki, et al.
Publicado: (2018)

Biomarkers to Improve Diagnosis and Monitoring of Obstructive Sleep Apnea Syndrome: Current Status and Future Perspectives
por: Archontogeorgis, Konstantinos, et al.
Publicado: (2014)

Formoterol in the management of chronic obstructive pulmonary disease
por: Steiropoulos, Paschalis, et al.
Publicado: (2008)

Lung Nodules and Hypoxemia: Any Association?
por: Chadia, Konstantina, et al.
Publicado: (2021)

Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadows
por: Takahara, Yutaka, et al.
Publicado: (2021)

Focusing on diffuse (interstitial) lung disease: a rapidly evolving field
por: du Bois, Roland M
Publicado: (2002)

Acute exacerbation of interstitial lung disease in the intensive care unit: Principles of diagnostic evaluation and management
por: Hayat Syed, Muhammad K, et al.
Publicado: (2023)

A case of invasive pulmonary aspergillosis during treatment for acute exacerbation of interstitial lung disease
por: Ugajin, Motoi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tmd2oiddtgi5uckoak9eqggevv